Transparency

Creating-Possible-Fund-HeroBanner_CA

Gilead complies with tax laws in the countries in which we conduct business. We perform governance procedures to ensure compliance and are committed to transparent and constructive relationships with all relevant tax authorities.

Find Out More About Our Global Tax Strategy Here

At Gilead, we strive to create a work environment where differences are valued, and people feel involved, respected and connected. The most recent UK gender pay report can be found here and the most recent report for Ireland is here.

Healthcare professionals, other relevant decision-makers and healthcare organisations with whom we work provide valuable, independent and expert knowledge derived from their clinical and management experience. This expertise makes an important contribution to our efforts to improve the quality of patient care, with benefits for individuals and society at large.

Find Out More About These Relationships Here

Learn More About Gilead’s Transparency Reporting

Gilead recognises the seriousness and importance of combatting modern slavery and human trafficking. We are committed to fully understanding and taking all appropriate action to address any slavery and human trafficking risks in our own business and in our supply chains.

Learn More Here

Gilead provides support to some patient organisations to help those organisations respond to the needs of the communities they look after. Read the 2023 report below, correct at the time of writing June 2024. The information is subject to change and periodic updates.

Gilead also engages members of the public for certain contracted services including speaking at meetings, assistance with training, writing articles and/or publications, participating in advisory boards, advising on the design etc of clinical trials and participating in market research where such participation involves remuneration and/or travel.

Read the reports below, correct at the time of writing June 2024. The information is subject to change and periodic updates.

UKI-COR-0030 May 2025